Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.

NCT06323824 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

600

Enrollment

OTHER

Sponsor class

Conditions

Opioid Use Disorder

Interventions

DRUG: Methadone
DRUG: Buprenorphine (BUP)

Sponsor

Yale University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]